Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


19.02.2018

2 Aliment Pharmacol Ther
2 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
2 Gastroenterology
1 Gut
10 Inflamm Bowel Dis
1 J Gastroenterol
1 Scand J Gastroenterol
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. LOBATON T, De Vos M
    Editorial: infliximab trough levels and histological healing in ulcerative colitis-a step towards personalised biologic therapy.
    Aliment Pharmacol Ther. 2018;47:855-856.
    PubMed     Text format    

  2. BARRE A, Colombel JF, Ungaro R
    Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018 Feb 12. doi: 10.1111/apt.14550.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. NOBILE S, Grand RJ, Pappa HM
    Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
    Eur J Gastroenterol Hepatol. 2018 Feb 12. doi: 10.1097/MEG.0000000000001076.
    PubMed     Text format     Abstract available

  4. AKAR M, Aydin F, Yurci MA, Abay S, et al
    The possible relationship between Campylobacter spp./Arcobacter spp. and patients with ulcerative colitis.
    Eur J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1097/MEG.0000000000001095.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  5. GOBBO M, Carmona L, Panadero A, Canas M, et al
    The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective.
    Gastroenterol Hepatol. 2018 Feb 5. pii: S0210-5705(18)30006.
    PubMed     Text format    


    Gastroenterology

  6. YE BD
    Introducing Traditional Herbal Medicine into Conventional Health Care in Treating Ulcerative Colitis: Primum Non Nocere.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30160.
    PubMed     Text format    

  7. PAPAMICHAEL K, Osterman MT, Siegel CA, Melmed GY, et al
    Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
    Gastroenterology. 2018 Feb 9. pii: S0016-5085(18)30006.
    PubMed     Text format    


    Gut

  8. BRYANT RV, Friedman A, Wright EK, Taylor K, et al
    Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application.
    Gut. 2018 Feb 3. pii: gutjnl-2017-315655. doi: 10.1136/gutjnl-2017-315655.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  9. HUANG Z, Chao K, Li M, Zhi M, et al
    Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Inflamm Bowel Dis. 2017;23:440-447.
    PubMed     Text format     Abstract available

  10. FAUBION WA, Dubinsky M, Ruemmele FM, Escher J, et al
    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:453-460.
    PubMed     Text format     Abstract available

  11. LU C, Gui X, Chen W, Fung T, et al
    Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2017;23:421-430.
    PubMed     Text format     Abstract available

  12. GHOSH S, Louis E, Beaugerie L, Bossuyt P, et al
    Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:333-340.
    PubMed     Text format     Abstract available

  13. COWARD S, Kuenzig ME, Hazlewood G, Clement F, et al
    Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Inflamm Bowel Dis. 2017;23:461-472.
    PubMed     Text format     Abstract available

  14. LOPETUSO LR, Jia R, Wang XM, Jia LG, et al
    Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.
    Inflamm Bowel Dis. 2017;23:392-403.
    PubMed     Text format     Abstract available

  15. SEINEN ML, van Asseldonk DP, de Boer NK, Bouma G, et al
    Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Inflamm Bowel Dis. 2017;23:448-452.
    PubMed     Text format     Abstract available

  16. CARLSEN K, Haddad N, Gordon J, Phan BL, et al
    Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:341-346.
    PubMed     Text format     Abstract available

  17. ZUNDLER S, Fischer A, Schillinger D, Binder MT, et al
    The alpha4beta1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo.
    Inflamm Bowel Dis. 2017;23:379-391.
    PubMed     Text format     Abstract available

  18. TARGOWNIK LE, Tennakoon A, Leung S, Lix LM, et al
    Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:409-420.
    PubMed     Text format     Abstract available


    J Gastroenterol

  19. MATSUOKA K, Kobayashi T, Ueno F, Matsui T, et al
    Evidence-based clinical practice guidelines for inflammatory bowel disease.
    J Gastroenterol. 2018 Feb 10. pii: 10.1007/s00535-018-1439.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  20. GREENSTEIN RJ, Brown ST
    A data-based hypothesis explicating the observations that "Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study".
    Scand J Gastroenterol. 2018 Feb 15:1. doi: 10.1080/00365521.2018.1440003.
    PubMed     Text format    


    Z Gastroenterol

  21. STALLMACH A, Anttila VJ, Hell M, Gwynn S, et al
    Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.
    Z Gastroenterol. 2018 Feb 9. doi: 10.1055/s-0044-100045.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: